Previous close | 10.77 |
Open | 13.10 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 290.00 |
Expiry date | 2024-05-17 |
Day's range | 9.73 - 14.20 |
Contract range | N/A |
Volume | |
Open interest | N/A |
(Bloomberg) -- Investors who may have missed out on the blistering rally in Eli Lilly & Co. and Novo Nordisk A/S are once again taking a chance with Amgen Inc.Most Read from BloombergTruce Talks Drag as Hamas Hits Israel Crossing in Deadly AttackAt $2 Million Per Minute, Treasuries Mint Cash Like Never BeforeJudge Threatens Trump With Jail Over Gag Order ViolationsTreasury Rally Risks Running Into a $125 Billion Brick WallBuffett Praises Apple After Trimming It, Drops Paramount StakeThe shares s
Amgen ( NASDAQ:AMGN ) First Quarter 2024 Results Key Financial Results Revenue: US$7.45b (up 22% from 1Q 2023). Net...
Insightful Analysis of Amgen Inc's Strengths, Weaknesses, Opportunities, and Threats